Market expert Sandip Sabharwal maintains a constructive long-term outlook but stresses selectivity due to near-term risks like rising input costs and competition. He favors midcaps and selective smallcaps, seeing opportunities in consumer durables, while cautioning on financials and quick commerce. Large pharma deals require careful integration and valuation assessment.
Did Goldiam International shares really crash 24% in one day? Here’s how the bonus math works
Goldiam International shares appeared to fall 24% after turning ex-bonus, but the decline was purely due to the 1:3 bonus share adjustment. Adjusted for the